Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for the quarter ending 2026-06-27 was 48.19%, a 37.69% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for the quarter ending 2026-03-28 was 52.48%, a 653.56% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for the quarter ending 2025-12-27 was -235.44%, a change of -212.13% year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for the quarter ending 2025-09-27 was 90.55%, a change of 444.91% year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for fiscal 2025 was -216.44%, a change of -191.90% from fiscal 2024.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for fiscal 2024 was -24.54%, a change of 110.08% from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for fiscal 2023 was -134.63%, a change of -74.85% from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. return tang equity for fiscal 2022 was -59.78%, a change of -27.46% from fiscal 2021.
Available history
2008-12-27 to 2026-06-27
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-2748.19%-$236.3M-$490.39M
2026-03-2852.48%-$182.84M-$348.43M
2025-12-27-235.44%-$142.16M$60.38M
2025-09-2790.55%-$79.62M-$87.93M
2025-06-2835.00%-$64.88M-$185.4M
2025-03-296.96%-$23.31M-$334.77M
2024-12-28-23.31%$25.29M-$108.51M
2024-09-28-354.36%$427.99M-$120.78M
2024-06-29-283.73%$445.72M-$157.09M
2024-03-30-175.14%$450.9M-$257.44M
2023-12-30-132.62%$480.37M-$362.21M
2023-09-30-103.36%$480.52M-$464.9M
2023-07-01-82.40%$490.12M-$594.78M
2023-04-01-66.74%$501.34M-$751.15M
2022-12-31-59.43%$492.61M-$828.89M
2022-09-24-39.68%$443.33M-$1.12B
2022-06-25-36.22%$450.88M-$1.24B
2022-03-26-38.91%$430.13M-$1.11B
2021-12-25-32.21%$398.84M-$1.24B
2021-09-25-28.60%$403.2M-$1.41B
2021-06-26-31.34%$400.65M-$1.28B
2021-03-27-75.34%$378.4M-$502.27M
2020-12-26-75.76%$365.31M-$482.17M
2020-09-26-44.13%$301.63M-$683.48M
2020-06-27-34.54%$272.57M-$789.19M
2020-03-28-27.30%$249.21M-$912.72M
2019-12-28-42.67%$254.06M-$595.39M
2019-09-28-33.81%$233.75M-$691.43M
2019-06-29-27.42%$221.1M-$806.32M
2019-03-30-52.24%$231.17M-$442.49M
2018-12-29-42.30%$228.72M-$540.69M
2018-09-29-22.16%$139.46M-$629.33M
2018-06-30-18.22%$131.51M-$721.61M
2018-03-31-198.38%$131.74M-$66.41M
2017-12-30-96.81%$125.45M-$129.59M
2017-09-30-129.55%$199.74M-$154.18M
2017-07-01-101.69%$184.82M-$181.75M
2017-04-01-66.47%$165.78M-$249.4M
2016-12-31-45.30%$156.37M-$345.2M
2016-09-24-49.13%$143.5M-$292.06M
2016-06-25-42.31%$143.33M-$338.77M
2016-03-26195.34%$157.02M$80.38M
2015-12-261124.66%$151.09M$13.43M
2015-09-261233.76%$146.4M$11.87M
2015-06-2765.42%$140.88M$215.35M
2015-03-2868.99%$127.45M$184.75M
2014-12-27182.30%$128.2M$70.32M
2014-09-2740.01%$119.97M$299.84M
2014-06-2840.46%$118.84M$293.71M
2014-03-2928.83%$110.74M$384.04M
2013-12-2831.64%$104.15M$329.18M
2013-09-2824.16%$103.24M$427.24M
2013-06-2922.41%$94.21M$420.43M
2013-03-3024.20%$97.09M$401.2M
2012-12-2924.95%$97.87M$392.2M
2012-09-2927.30%$106.57M$390.29M
2012-06-3028.17%$103.26M$366.61M
2012-03-3129.71%$105.09M$353.72M
2011-12-3133.53%$109.98M$328.02M
2011-09-24-78.03%-$265.23M$339.91M
2011-06-25-80.01%-$309.36M$386.66M
2011-03-26-90.81%-$327.69M$360.86M
2010-12-25-69.96%-$342.12M$488.99M
2010-09-254.28%$22.95M$536.2M
2010-06-269.51%$85.17M$895.88M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-27-216.44%-$142.16M$65.68M
2024-12-28-24.54%$25.29M-$103.06M
2023-12-30-134.63%$480.37M-$356.82M
2022-12-31-59.78%$492.61M-$824.1M
2021-12-25-32.32%$398.84M-$1.23B
2020-12-26-76.33%$365.31M-$478.6M
2019-12-28-42.90%$254.06M-$592.15M
2018-12-29-42.49%$228.72M-$538.24M
2017-12-30-98.58%$125.45M-$127.26M
2016-12-31-45.61%$156.37M-$342.84M
2015-12-26842.98%$151.09M$17.92M
2014-12-2737.62%$128.2M$340.81M
2013-12-2831.34%$104.15M$332.28M
2012-12-2924.80%$97.87M$394.59M
2011-12-3133.35%$109.98M$329.8M
2010-12-25-104.01%-$342.12M$328.93M
2009-12-2662.39%$112.6M$180.49M
2008-12-27-42.30%-$525.19M$1.24B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71